Anti-interferon-gamma autoantibody syndrome and opportunistic skin infections: a case report and literature review

Authors

  • Arisa Kaewkes Department of internal medicine, Faculty of medicine, Thummasat University
  • Padcha Pongcharoen Department of internal medicine, Faculty of medicine, Thummasat University

Keywords:

anti-IFN-γ autoantibodies, Opportunistic infections, Mycobacteriosis, Talaromycosis

Abstract

In adulthood, patients with acquired anti-interferon-gamma (anti-IFN-) autoantibody syndrome usually suffer from recurrent and recalcitrant disseminated non-tuberculous mycobacterial (NTM) diseases with or without other opportunistic infections. We describe a case of HIV-negative, IFN- antibody positive, Thai adult who presented with disseminated Mycobacterium avium complex co-infection with cutaneous Talaromyces marneffei and Mycobacterium abscessus lymphadenitis. Anti-IFN- autoantibody syndrome should be considered in the differential diagnosis of HIVnegative adults who present with unusual, severe, or recurrent skin infections caused by NTM or other opportunistic pathogens, especially in Asian patients.

References

1. Tang BS, Chan JF, Chen M, et al. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol. 2010;17:1132-8.

2. Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012; 367: 725-4.

3. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis. 1996;23:125-30.

4. El-Atrouni W, Berbari E, Temesgen Z. HIVassociated opportunistic infections. Bacterial infections. Le Journal medical libanais. J Med Liban. 2006; 54:80-3.

5. Browne SK. Anticytokine autoantibody-associated immunodeficiency. Annu Rev Immunol. 2014;32:635-657.

6. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev. 2000; 11:321-33.

7. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994; 84: 4008-27.

8. Doffinger R, Patel S, Kumararatne DS. Human immunodeficiencies that predispose to intracellular bacterial infections. Curr Opin Rheumatol. 2005; 17: 440-6.

9. Chi CY, Chu CC, Liu JP, et al. Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLADQB1* 05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013; 121: 1357-66.

10. Kampitak T, Suwanpimolkul G, Browne S, Suankratay C. Anti-interferon-gamma autoantibody and opportunistic infections: case series and review of the literature. Infection. 2011; 39: 65-71.

11. Pithukpakorn M, Roothumnong E, Angkasekwinai N, et al. HLA-DRB1 and HLA-DQB1 Are Associated with Adult-Onset Immunodeficiency with Acquired Anti-Interferon-Gamma Autoantibodies. PloS one. 2015; 10: e0128481.

12. Browne SK, Zaman R, Sampaio EP, et al. Anti- CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection. Blood. 2012; 119:3933-9.

13. Doffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004; 38: e10-4.

14. Koya T, Tsubata C, Kagamu H, et al. Antiinterferon- gamma autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother 2009; 15: 118-22.

15. Holland SM, Eisenstein EM, Kuhns DB, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med 1994; 330: 1348-55.

16. Keating GM. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma. Drugs. 2010; 70: 1445-76.

17. Czaja CA, Merkel PA, Chan ED, et al. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-gamma autoantibody. Clin Infect Dis 2014; 58: e115-118.

18. Pruetpongpun N, Khawcharoenporn T, Damronglerd P, et al. Disseminated Talaromyces marneffei and Mycobacterium abscessus in a Patient With Anti-Interferon-gamma Autoantibodies. Open Forum Infect Dis. 2016; 3: ofw093.

19. Wongkulab P, Wipasa J, Chaiwarith R, Supparatpinyo K. Autoantibody to interferongamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand. PloS one. 2013; 8: e76371.

Downloads

Published

2018-12-04

How to Cite

Kaewkes, A., & Pongcharoen, P. (2018). Anti-interferon-gamma autoantibody syndrome and opportunistic skin infections: a case report and literature review. Thai Journal of Dermatology, 34(3), 192–199. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/158904